| aa | Amino Acids |
| ADCC | Antibody-Dependent Cellular Cytotoxicity |
| AFP | Alpha-Fetoprotein |
| ALK1/2/5 | Activin Receptor-Like Kinase 1/2/5 |
| ASF/SF2 | Alternative Splicing Factor/Splicing Factor-2 |
| BMPs | Bone Morphogenetic Proteins |
| CD | Cluster of Differentiation 31, 34, 105, etc. |
| CSS | Cancer-Specific Survival |
| CTGF | Connective Tissue Growth Factor |
| CXCL12 | C-X-C Motif Chemokine 12 or Stromal Cell-Derived Factor 1 (SDF1) |
| DFS | Disease-Free Survival |
| ECs | Endothelial Cells |
| ECM | Extracellular Matrix |
| EGF/R | Epidermal Growth Factor/Receptor |
| EndMT | Endothelial-to-Mesenchymal Transition |
| ENG | Endoglin (CD105) |
| eNOS | Endothelial Nitric Oxide Synthase |
| EPCs/BM-EPCs | Endothelial Progenitor Cells; Bone-Marrow EPCs |
| ERK1/2 | Extracellular Signal-Regulated Kinase 1/2 |
| FGF/bFGF | Fibroblast Growth Factor/Basic FGF |
| HBV/HCV | Hepatitis B/C Virus |
| HCC | Hepatocellular Carcinoma |
| HHT1 | Hemorrhagic Teleangiectasia Type 1 |
| HIF | Hypoxia-Inducible Transcription Factor |
| HRE | Hypoxia-Responsive Element |
| HSCs | Hepatic Stellate Cells |
| HUVECs | Human Umbilical Vein ECs |
| ID1 | DNA Binding Protein 1 |
| IHC | Immunohistochemistry |
| IL | Interleukin |
| INR | International Normalized Ratio of Prothrombin Time of Blood Coagulation |
| KLF6 | Kruppel-Like Factor 6 |
| L-ENG | Long-ENG |
| LOXL2 | Lysyl Oxidase Like-2 |
| LSECs | Liver Sinusoidal Endothelial Cells |
| MAPK | Mitogen-Activated Protein Kinase (Originally Called ERK) |
| MMP2, -14 | Metalloproteinase 2, -14 |
| MVD/IMVD | Microvessels Density/Intratumoral MVD |
| NF-κB | Nuclear Factor Kappa-Light-Chain-Enhancer of Activated B Cells |
| OR | Odds Ratio |
| OS | Overall Survival |
| PD-ECGF | Platelet-Derived Endothelial Cell Growth Factor |
| PDGF/R | Platelet-Derived Growth Factor/Receptor |
| PFS | Progression-Free Survival |
| PIGF | Placental Growth Factor |
| PVTT | Portal Vein Tumour Thrombus |
| RGD domain | Arg-Gly-Asp Domain |
| S-ENG | Short ENG |
| αSMA | Smooth Muscle Actin α |
| SMAD | The Main Signal Transducers for Receptors of TGF-β Family |
| Sol-ENG | Soluble Endoglin |
| TAF | Tumour-Angiogenesis Factor |
| TARE | Transarterial Radioembolization |
| TECs | Tumour Endothelial Cells |
| TGF-α, β | Transforming Growth Factor α, β |
| TIMP1/2 | Tissue Inhibitors of Metalloproteinase 1 and 2 |
| TNF-α | Tumour Necrosis Factor α |
| TNM | Classification of Malignant Tumours (T—tumour; N—lymph nodes; M—metastasis) |
| TRC | Anti-CD105 Monoclonal Antibody |
| TRE | Thyroid Hormone Response Element |
| TSP-1 | Thrombospondin-1 |
| VEGF/R | Vascular Endothelial Growth Factor/Receptor |
| ZRP-1 | Zyxin-Related Protein 1 |